Compliance to Live Oral Ty21a Typhoid Vaccine, and its Effect on Viability | Zendy

Claire-Lise Fallab Stubi | Zendy; Pierre Landry | Zendy; Christiane Pétignat | Zendy; Jacques Billé | Zendy; Blaise Genton | Zendy; Roger Darioli | Zendy; Michel Burnier | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Compliance to Live Oral Ty21a Typhoid Vaccine, and its Effect on Viability

Author(s) -

Claire-Lise Fallab Stubi,

Pierre Landry,

Christiane Pétignat,

Jacques Billé,

Blaise Genton,

Roger Darioli,

Michel Burnier

Publication year - 2006

Publication title -

journal of travel medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.985

H-Index - 59

eISSN - 1708-8305

pISSN - 1195-1982

DOI - 10.2310/7060.2000.00044

Subject(s) - medicine , dosing , typhoid vaccine , pill , typhoid fever , patient compliance , anesthesia , emergency medicine , pharmacology , virology

Concerns have been expressed that in travelers the efficacy of the live oral Ty21a typhoid vaccine Vivotif could be lower than reported, maybe due to a lack of compliance. The purpose of this study was to examine the level of compliance with the recommendations regarding dosing, timing of dosing with respect to food intake, and storage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research